AMRX EBITDA Growth
Amneal Pharmaceuticals Inc Class A · EBITDA Growth
AMRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported11.70%period ending
AMRX TTM EBITDA YoY % (-49.73% → 11.70%)
Year-over-year change
High-resolution chart · PNG
AMRX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 11.7023% | |
| 15.8027% | |
| 37.3145% | |
| 54.209% | |
| 66.1115% | |
| 57.9166% | |
| 10.0095% | |
| -22.8714% | |
| -20.5252% | |
| 107.749% | |
| 165.753% | |
| 262.6602% | |
| 283.9826% | |
| -55.7565% | |
| -62.4966% | |
| -68.6734% | |
| -70.5441% | |
| 11.627% | |
| 16.0565% | |
| 40.4899% | |
| 14.2782% | |
| 10.0997% | |
| 122.6865% | |
| 50.2973% | |
| 69.7304% | |
| 1,825.0266% | |
| 42.8527% | |
| 31.4585% | |
| 121.6361% | |
| -105.2456% | |
| -64.7004% | |
| -49.7343% |